scispace - formally typeset
G

Gabor Abellan van Kan

Researcher at University of Toulouse

Publications -  56
Citations -  8451

Gabor Abellan van Kan is an academic researcher from University of Toulouse. The author has contributed to research in topics: Sarcopenia & Cognitive decline. The author has an hindex of 31, co-authored 51 publications receiving 7043 citations. Previous affiliations of Gabor Abellan van Kan include French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force

TL;DR: Gait speed at usual pace was found to be a consistent risk factor for disability, cognitive impairment, institutionalisation, falls, and/or mortality in older adults as mentioned in this paper, and the use of simple, safe, and easy to perform assessment tool, like gait speed, to evaluate vulnerability to adverse outcomes in community-dwelling older people is appealing.
Journal ArticleDOI

The frailty phenotype and the frailty index: different instruments for different purposes

TL;DR: The designs and rationals of the frailty phenotype and Frailty Index are discussed, proposing the correct ways for having them implemented in the clinical setting.
Journal ArticleDOI

Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.

Sandrine Andrieu, +132 more
- 01 May 2017 - 
TL;DR: The multidomain intervention and polyunsaturated fatty acids, either alone or in combination, had no significant effects on cognitive decline over 3 years in elderly people with memory complaints.
Journal ArticleDOI

Frailty: toward a clinical definition

TL;DR: A Geriatric Advisory Panel of the International A emy of Nutrition and Aging has postulated a new approa defining frailty and a case-finding tool, which stressed that for frailty to be a useful clinical tion, it should be considered a predisability state.